Frailty Assessment of Patients With Gastrointestinal Surgery

November 11, 2020 updated by: Ziqiang Wang,MD

Application of Frailty Assessment in Elderly Patients Undergoing Gastrointestinal Surgery

Patients aged 65 or older under gastrointestinal surgery will be enrolled,the investigators will assess the frailty of these patients by Frailty Index Scale and explore the correlation between the frailty and perioperative adverse events.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Patients will be assessed by specially trained doctors or nurses after admission, including daily living ability, physiological function, social-psychological status, comorbidities, mental state, grip strength, walking speed. After the assessment, the patients' frailty index was obtained. Moreover, the operation time, intraoperative bleeding loss, perioperative complications, length of stay, hospitalization expenses, readmission rate within 30 days, mortality within 30 days and other outcome indicators of these patients will be recorded.

The Main purposes of present study are to verify the feasibility of applying Frailty Index (FI) to assess the degree of frailty in elderly patients undergoing gastrointestinal surgery, compare the difference of perioperative adverse events in elderly patients with different degrees of frailty,find potential indicators for evaluating and predicting the safety of surgery in elderly patients, and provide reference data for the determination of future assessment tools of frailty.

The secondary objective is to compare the quality of life and long-term prognosis(only for patients with cancers,including recurrence free survival and overall survival) of elderly patients with different degrees of frailty after gastrointestinal surgery.

Study Type

Observational

Enrollment (Anticipated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sichuan
      • Chengdu, Sichuan, China, 610041
        • West China Hospital, Sichuan University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Elderly patients aged 65 years or older who undergo gastrointestinal surgery in West China Hospital.

Description

Inclusion Criteria:

  • Patients whose age not less than 65 years;
  • undergoing operation in gastrointestinal surgery of West China hospital due to gastrointestinal disease.

Exclusion Criteria:

  • Those who did not undergo surgery for various reasons;
  • Death before operation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
operative time
Time Frame: 2 year
From the beginning of the skin incision to the end of the last incision was From the beginning of the skin incision to the end of the suture of last incision
2 year
Blood loss
Time Frame: 2 year
intraoperative blood loss
2 year
Intraoperative complications
Time Frame: 2 year
Including all the complications in the procedure
2 year
postoperative complications
Time Frame: 2 year
including incision infection,anastomotic leakage,respiratory infection, postoperative bleeding and so on.
2 year
The length of stay in intensive care unit (ICU)
Time Frame: 2 year
Time form entry to ICU to return to general ward after the condition is stable.
2 year
The length of hospitalization
Time Frame: 2 year
Time from admission to discharge
2 year
Hospital costs
Time Frame: 2 year
Cost of diagnosis and treatment during hospitalization
2 year
Readmission rate within 30 days
Time Frame: 2 year
The proportion of patients who are re-hospitalized for postoperative complications after 30 days of discharge in all subjects.
2 year
Mortality within 30 days
Time Frame: 2 year
death rate within 30 days after surgery in all patients after operation
2 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recurrence-free Survival (RFS)
Time Frame: 2 year
RFS is the abbreviation of recurrence-free survival, which refers to the duration from postoperation to tumor recurrence (Only for patients with cancers).
2 year
Overall survival (OS)
Time Frame: 2 year
OS is the abbreviation of overall survival , which refers to the duration from postoperation to death of the subjects (Only for patients with cancers).
2 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Ziqiang Wang, MD,PHD, Department of Gastrointestinal Surgery, West China Hospital, Sichuan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Anticipated)

January 1, 2021

Study Completion (Anticipated)

January 1, 2021

Study Registration Dates

First Submitted

April 4, 2019

First Submitted That Met QC Criteria

April 25, 2019

First Posted (Actual)

April 29, 2019

Study Record Updates

Last Update Posted (Actual)

November 13, 2020

Last Update Submitted That Met QC Criteria

November 11, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frail Elderly Syndrome

Clinical Trials on Frailty Index Scale

3
Subscribe